<- Go Home
Khiron Life Sciences Corp.
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Market Cap
$332.00
Volume
207.0K
Cash and Equivalents
$1.9M
EBITDA
-$16.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$6.7M
Profit Margin
41.34%
52 Week High
$0.01
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.00
Price / Earnings
-0.00
Price / Tangible Book Value
0.00
Enterprise Value
$9.9M
Enterprise Value / EBITDA
-0.63
Operating Income
-$17.4M
Return on Equity
74.68%
Return on Assets
-20.79
Cash and Short Term Investments
$1.9M
Debt
$2.6M
Equity
$27.1M
Revenue
$16.1M
Unlevered FCF
-$8.6M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium